Edmund Harrigan's Net Worth
Edmund Harrigan's net worth is estimated to be at least $2,811,390.00 as of 05/07/2024. CoreStreet's estimation of Edmund Harrigan's net worth is based on their sale of stock and current holding of stock.
Edmund Harrigan is Director at PhaseBio Pharmaceuticals Inc. They have executed at least 3 trades of stock as per SEC Form 4 filings. Their most recent trade was for 6,000 units of PHAS stock on 12/03/2020. Their biggest sale was on 06/12/2020 when they sold 30,000 units of Karuna Therapeutics Inc stock for $2,753,700.00. They typically trade 1 times per year.
Total value of insider buys:
- $57,690.00
Total value of insider sells:
- $2,753,700.00
Most recent insider trade:
- Dec. 3, 2020
Edmund Harrigan's Insider Trading History
| PhaseBio Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 3, 2020 | Director | 6,000 | $4.12 | Buy | $24,720.00 |
| Karuna Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 12, 2020 | Director | 30,000 | $91.79 | Sell | $2,753,700.00 |
| ACADIA Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 16, 2016 | Director | 1,000 | $32.97 | Buy | $32,970.00 |